CRP and type 2 diabetes mellitus: In the Insulin Resistance Atherosclerosis Study, the addition of CRP to a prediction model for type 2 diabetes that was based on the metabolic syndrome (without or with an estimate of insulin resistance) had little impact on AUCs [34].